)
Avicanna (AVCN) investor relations material
Avicanna Status Update summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Business model and strategic evolution
Transitioned from pharmaceutical R&D to commercializing medical cannabis products, leveraging proprietary drug delivery systems and technologies.
Operates four business pillars: RHO Phyto (medical products), MyMedi (medical cannabis care platform), pharmaceutical pipeline, and Aureus (API/raw materials division in Colombia).
Asset-light model in Canada, licensing technology to 10 licensed producers and expanding through 15 commercial channels.
International expansion includes exports to Europe and Australia, and collaborations in the US and South America.
Strategic partnerships with Fortune 100/500 and leading cannabis companies, plus ongoing M&A exploration.
Product and R&D advancements
Expanded commercial SKUs in Canada by 24% to 52, with increased listings and entry into new medical channels.
RHO Phyto portfolio includes 30 proprietary SKUs, now with minor cannabinoids, and is supported by clinical trials and real-world evidence studies.
Launched new patented technologies: deep tissue gel/spray, Influit (self-emulsifying system), and PwdRx (powder delivery), with promising preclinical results.
Aureus division now produces GACP and organic certified flower, exporting to Switzerland and targeting Europe and Australia.
Trunerox, a 10% CBD pharmaceutical for epilepsy, launched in Colombia, leveraging low-cost manufacturing.
Medical platform and clinical engagement
MyMedi platform expanded, offering comprehensive patient support, insurance processing, and treatment planning.
Enhanced educational initiatives, partnerships, and programs for prescribers, institutions, and patients.
Hosted Avicanna Symposium with 400+ medical professionals, reinforcing leadership in cannabinoid research.
Developed Morpheus patient intelligence platform for real-world data and treatment optimization.
Advanced clinical studies: national real-world evidence study (450+ patients) and phase II RCT for osteoarthritic pain.
Next Avicanna earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)